Jones Kareen L, Greenberg Robert S, Ahn Edward S, Kudchadkar Sapna R
Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University 1800 Orleans Street, Baltimore, MD 21287,United States.
Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins University 1800 Orleans Street, Baltimore, MD 21287,United States; Department of Pediatrics, The Johns Hopkins University, 1800 Orleans Street, Baltimore, MD 21287,United States.
Int J Surg Case Rep. 2016;24:77-9. doi: 10.1016/j.ijscr.2016.05.004. Epub 2016 May 6.
Congenital factor VII deficiency is a rare bleeding disorder with high phenotypic variability. It is critical that children with congenital Factor VII deficiency be identified early when high-risk surgery is planned. Cranial vault surgery is common for children with craniosynostosis, and these surgeries are associated with significant morbidity mostly secondary to the risk of massive blood loss.
A two-month old infant who presented for elective craniosynostosis repair was noted to have an elevated prothrombin time (PT) with a normal activated partial thromboplastin time (aPTT) on preoperative labs. The infant had no clinical history or reported family history of bleeding disorders, therefore a multidisciplinary decision was made to repeat the labs under general anesthesia and await the results prior to incision. The results confirmed the abnormal PT and the case was canceled. Hematologic workup during admission revealed factor VII deficiency. The patient underwent an uneventful endoscopic strip craniectomy with perioperative administration of recombinant Factor VIIa.
Important considerations for perioperative laboratory evaluation and management in children with factor VII deficiency are discussed. Anesthetic and surgical management of the child with factor VII deficiency necessitates meticulous planning to prevent life threatening bleeding during the perioperative period.
A thorough history and physical examination with a high clinical suspicion are vital in preventing hemorrhage during surgeries in children with coagulopathies. Abnormal preoperative lab values should always be confirmed and addressed before proceeding with high-risk surgery. A multidisciplinary discussion is essential to optimize the risk-benefit ratio during the perioperative period.
先天性因子VII缺乏症是一种罕见的出血性疾病,具有高度的表型变异性。当计划进行高风险手术时,尽早识别先天性因子VII缺乏症患儿至关重要。颅骨手术在患有颅缝早闭的儿童中很常见,这些手术大多因大量失血风险而伴有显著的发病率。
一名两个月大的婴儿因择期颅缝早闭修复手术就诊,术前实验室检查发现其凝血酶原时间(PT)升高,活化部分凝血活酶时间(aPTT)正常。该婴儿无出血性疾病的临床病史或家族史报告,因此做出多学科决定,在全身麻醉下重复实验室检查并等待结果后再行切开。结果证实PT异常,手术取消。入院期间的血液学检查发现因子VII缺乏。患者在围手术期给予重组因子VIIa后,顺利接受了内镜下颅骨条带切除术。
讨论了因子VII缺乏症患儿围手术期实验室评估和管理的重要注意事项。因子VII缺乏症患儿的麻醉和手术管理需要精心规划,以防止围手术期发生危及生命的出血。
详细的病史和体格检查以及高度的临床怀疑对于预防凝血障碍患儿手术期间的出血至关重要。术前实验室检查异常值在进行高风险手术前应始终予以确认和处理。多学科讨论对于优化围手术期的风险效益比至关重要。